Rathan M. Subramaniam

Author

Also Known As

L M GHOSH, R SUBRAMANIAM, R Subramaniam, R. M. Subramaniam, R. SUBRAMANIAM, R. Subramaniam, R.M. Subramaniam, RM Subramaniam, Ratham M. Subramaniam, Rathan M Subramaniam

435

Publications

10.7K

Citations

H-Index

147

Concepts

All Affiliations

Johns Hopkins University The University of Texas Southwestern Medical Center Boston University Mayo Clinic Boston Medical Center

About

Rathan M. Subramaniam is an author at Johns Hopkins University specializing in medicine, radiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	43	1.3K
2	Health Sciences	20	33	987
3	Engineering	10	12	297
4	Education	1	1	18
5	Nursing	1	1	18

Rathan M. Subramaniam

141

Publications

Citations

H-Index

Page 1

	Year	Citations
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002) Sue S. Yom, Pedro A. Torres‐Saavedra, Jimmy J. Caudell, Journal of Clinical Oncology	2021	344
Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction Christian Kurts, Jacques F.A.P. Miller, Rathan M. Subramaniam, The Journal of Experimental Medicine	1998	316
<sup>18</sup>F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging Elizabeth H. Dibble, Ana Centeno Álvarez, Minh-Tam Truong, Journal of Nuclear Medicine	2012	216
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing Christine H. Chung, Violeta Beleva Guthrie, David L. Masica, Annals of Oncology	2015	202
Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)—Interreader Reliability, Accuracy, and Survival Outcomes Charles Marcus, Anthony Ciarallo, Abdel Tahari, Journal of Nuclear Medicine	2014	180
Clinical Significance of Diffusely Increased 18F-FDG Uptake in the Thyroid Gland Dimitrios Karantanis, Trond Velde Bogsrud, Gregory A. Wiseman, Journal of Nuclear Medicine	2007	149
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma Vasavi Paidpally, Alin Chirindel, S. Lam, Imaging in Medicine	2012	123
Fluorodeoxyglucose–Positron-Emission Tomography Imaging of Head and Neck Squamous Cell Cancer Rathan M. Subramaniam, M. Truong, Patrick J. Peller, American Journal of Neuroradiology Oncologic ImagingPet-mriPathologyPositron Emission TomographyOncology	2009	112
Multicenter Trial of [<sup>18</sup>F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685 Val J. Lowe, Fenghai Duan, Rathan M. Subramaniam, Journal of Clinical Oncology	2019	104
Appropriate Use Criteria for <sup>18</sup>F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease Hossein Jadvar, Patrick M. Colletti, Roberto C. Delgado Bolton, Journal of Nuclear Medicine	2017	95

Page 1